User menu

L'attitude de l'enfant envers une nouvelle marque: de la nécessité d'une phase de fixation ?

Bibliographic reference Pecheux, Claude ; Derbaix, Christian. L'attitude de l'enfant envers une nouvelle marque: de la nécessité d'une phase de fixation ?. In: Recherche et Applications en Marketing, Vol. 17, no. 3, p. 63-79 (2002)
Permanent URL
  1. Abdelmalek Manal F., Suzuki Ayako, Guy Cynthia, Unalp-Arida Aynur, Colvin Ryan, Johnson Richard J., Diehl Anna Mae, , Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease, 10.1002/hep.23535
  2. Alisi Anna, Bedogni Giorgio, De Vito Rita, Comparcola Donatella, Manco Melania, Nobili Valerio, Relationship between portal chronic inflammation and disease severity in paediatric non-alcoholic fatty liver disease, 10.1016/j.dld.2010.05.007
  3. Alisi Anna, Feldstein Ariel E., Villani Alberto, Raponi Massimiliano, Nobili Valerio, Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach, 10.1038/nrgastro.2011.273
  4. Alisi Anna, Manco Melania, Vania Andrea, Nobili Valerio, Pediatric Nonalcoholic Fatty Liver Disease in 2009, 10.1016/j.jpeds.2009.06.014
  5. Alisi Anna, Nobili Valerio, Nonalcoholic fatty liver disease: Targeted therapy in children—what is the right way?, 10.1038/nrgastro.2011.117
  6. Alkhouri Naim, Carter–Kent Christine, Lopez Rocio, Rosenberg William M., Pinzani Massimo, Bedogni Giorgio, Feldstein Ariel E., Nobili Valerio, A Combination of the Pediatric NAFLD Fibrosis Index and Enhanced Liver Fibrosis Test Identifies Children With Fibrosis, 10.1016/j.cgh.2010.09.015
  7. Alkhouri Naim, De Vito Rita, Alisi Anna, Yerian Lisa, Lopez Rocio, Feldstein Ariel E., Nobili Valerio, Development and validation of a new histological score for pediatric non-alcoholic fatty liver disease, 10.1016/j.jhep.2012.07.027
  8. Angulo Paul, Nonalcoholic Fatty Liver Disease, 10.1056/nejmra011775
  9. Brunt Elizabeth M., Pathology of nonalcoholic fatty liver disease, 10.1038/nrgastro.2010.21
  10. Brunt Elizabeth M., Janney Christine G., Bisceglie Adrian M., Neuschwander-Tetri Brent A., Bacon Bruce R., Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions, 10.1111/j.1572-0241.1999.01377.x
  11. Brunt Elizabeth M, Histopathology of nonalcoholic fatty liver disease, 10.3748/wjg.v16.i42.5286
  12. Burt AD, Mutton A, Day CP (1998) Diagnosis and interpretation of steatosis and steatohepatitis. Semin Diagn Pathol 15:246–258
  13. Cani P. D., Bibiloni R., Knauf C., Waget A., Neyrinck A. M., Delzenne N. M., Burcelin R., Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet-Induced Obesity and Diabetes in Mice, 10.2337/db07-1403
  14. Carter-Kent Christine, Yerian Lisa M., Brunt Elizabeth M., Angulo Paul, Kohli Rohit, Ling Simon C., Xanthakos Stavra A., Whitington Peter F., Charatcharoenwitthaya Phunchai, Yap Jason, Lopez Rocio, McCullough Arthur J., Feldstein Ariel E., Nonalcoholic steatohepatitis in children: A multicenter clinicopathological study, 10.1002/hep.23133
  15. Day C. P., Non-alcoholic fatty liver disease: a massive problem, 10.7861/clinmedicine.11-2-176
  16. DeBoer Mark D, Ethnicity, obesity and the metabolic syndrome: implications on assessing risk and targeting intervention, 10.1586/eem.11.17
  17. Della Corte Claudia, Alisi Anna, Saccari Alessia, De Vito Rita, Vania Andrea, Nobili Valerio, Nonalcoholic Fatty Liver in Children and Adolescents: An Overview, 10.1016/j.jadohealth.2012.01.010
  18. Esposito E., Iacono A., Bianco G., Autore G., Cuzzocrea S., Vajro P., Canani R. B., Calignano A., Raso G. M., Meli R., Probiotics Reduce the Inflammatory Response Induced by a High-Fat Diet in the Liver of Young Rats, 10.3945/jn.108.101808
  19. Feldstein Ariel E, Nobili Valerio, Biomarkers in Nonalcoholic Fatty Liver Disease: A New Era in Diagnosis and Staging of Disease in Children : , 10.1097/mpg.0b013e3181ecf3d4
  20. Fitzpatrick Emer, Mitry Ragai R, Quaglia Alberto, Hussain Munther J, deBruyne Ruth, Dhawan Anil, Serum Levels of CK18 M30 and Leptin Are Useful Predictors of Steatohepatitis and Fibrosis in Paediatric NAFLD : , 10.1097/mpg.0b013e3181e376be
  21. Fraser Abigail, Longnecker Matthew P., Lawlor Debbie A., Prevalence of Elevated Alanine Aminotransferase Among US Adolescents and Associated Factors: NHANES 1999–2004, 10.1053/j.gastro.2007.08.077
  22. Frasinariu Otilia E., Ceccarelli Sara, Alisi Anna, Moraru Evelina, Nobili Valerio, Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: An input for novel therapies, 10.1016/j.dld.2012.11.010
  23. Fuchs Michael, Non-Alcoholic Fatty Liver Disease: The Bile Acid-Activated Farnesoid X Receptor as an Emerging Treatment Target, 10.1155/2012/934396
  24. Kechagias S., Ernersson A., Dahlqvist O., Lundberg P., Lindstrom T., Nystrom F. H., , Fast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects, 10.1136/gut.2007.131797
  25. Kleiner David E., Brunt Elizabeth M., Van Natta Mark, Behling Cynthia, Contos Melissa J., Cummings Oscar W., Ferrell Linda D., Liu Yao-Chang, Torbenson Michael S., Unalp-Arida Aynur, Yeh Matthew, McCullough Arthur J., Sanyal Arun J., , Design and validation of a histological scoring system for nonalcoholic fatty liver disease, 10.1002/hep.20701
  26. Ko Jae Sung, Yoon Jung Min, Yang Hye Ran, Myung Jae Kyung, Kim Hye Ryeung, Kang Gyeong Hoon, Cheon Jung-Eun, Seo Jeong Kee, Clinical and Histological Features of Nonalcoholic Fatty Liver Disease in Children, 10.1007/s10620-009-0949-3
  27. Koot B. G. P., van der Baan-Slootweg O. H., Tamminga-Smeulders C. L. J., Rijcken T. H. P., Korevaar J. C., van Aalderen W. M., Jansen P. L. M., Benninga M. A., Lifestyle intervention for non-alcoholic fatty liver disease: prospective cohort study of its efficacy and factors related to improvement, 10.1136/adc.2010.199760
  28. Lavine Joel E., Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents : The TONIC Randomized Controlled Trial, 10.1001/jama.2011.520
  29. Lee Jinmi, Hong Seok-Woo, Rhee Eun-Jung, Lee Won-Young, GLP-1 Receptor Agonist and Non-Alcoholic Fatty Liver Disease, 10.4093/dmj.2012.36.4.262
  30. Li Wenjun, Zheng Liu, Sheng Chunjun, Cheng Xiaoyun, Qing Liu, Qu Shen, Systematic review on the treatment of pentoxifylline in patients with non-alcoholic fatty liver disease, 10.1186/1476-511x-10-49
  31. Loguercio Carmela, Federico Alessandro, Tuccillo Concetta, Terracciano Fulvia, D??Auria Mauro Valeriano, De Simone Claudio, Blanco Camillo Del Vecchio, Beneficial Effects of a Probiotic VSL#3 on Parameters of Liver Dysfunction in Chronic Liver Diseases : , 10.1097/01.mcg.0000165671.25272.0f
  32. Ludwig J, Viggiano TR, McGill DB, Oh BJ (1980) Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55:434–438
  33. Manco Melania, Alisi Anna, Nobili Valerio, Risk of severe liver disease in NAFLD with normal ALT levels: A pediatric report, 10.1002/hep.22631
  34. Marra Fabio, Gastaldelli Amalia, Svegliati Baroni Gianluca, Tell Gianluca, Tiribelli Claudio, Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis, 10.1016/j.molmed.2007.12.003
  35. MASTERTON G. S., PLEVRIS J. N., HAYES P. C., Review article: omega-3 fatty acids - a promising novel therapy for non-alcoholic fatty liver disease : REVIEW: OMEGA-3 FATTY ACIDS - A NOVEL THERAPY FOR NAFLD?, 10.1111/j.1365-2036.2009.04230.x
  36. Mencin AA, Lavine JE (2011) Nonalcoholic fatty liver disease in children. Curr Opin Clin Nutr Metab Care 14:151–157
  37. Miura Kouichi, Seki Ekihiro, Ohnishi Hirohide, Brenner David A., Role of Toll-Like Receptors and Their Downstream Molecules in the Development of Nonalcoholic Fatty Liver Disease, 10.1155/2010/362847
  38. Moran JR, Ghishan FK, Halter SA, Greene HL (1983) Steatohepatitis in obese children: a cause of chronic liver dysfunction. Am J Gastroenterol 78:374–377
  39. Nadeau Kristen J, Ehlers Lindsay B, Zeitler Philip S, Love-Osborne Kathy, Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents, 10.1111/j.1399-5448.2008.00450.x
  40. Nobili V, Alisi A, Della CC, Rise P, Galli C, Agostoni C, Bedogni G (2012) Docosahexaenoic acid for the treatment of fatty liver: randomised controlled trial in children. Nutr Metab Cardiovasc Dis. doi: 10.1016/j.numecd.2012.10.010
  41. Nobili Valerio, Alisi Anna, Vania Andrea, Tiribelli Claudio, Pietrobattista Andrea, Bedogni Giorgio, The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease, 10.1186/1741-7015-7-21
  42. Nobili V., Bedogni G., Alisi A., Pietrobattista A., Rise P., Galli C., Agostoni C., Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial, 10.1136/adc.2010.192401
  43. Nobili Valerio, Carpino Guido, Alisi Anna, Franchitto Antonio, Alpini Gianfranco, De Vito Rita, Onori Paolo, Alvaro Domenico, Gaudio Eugenio, Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease, 10.1002/hep.25742
  44. NOBILI V, MANCO M, CIAMPALINI P, ALISI A, DEVITO R, BUGIANESI E, MARCELLINI M, MARCHESINI G, Metformin use in children with nonalcoholic fatty liver disease: An open-label, 24-month, observational pilot study, 10.1016/j.clinthera.2008.06.012
  45. Nobili V, Manco M, Devito R, Di C, V, Comparcola D, Sartorelli MR, Piemonte F, Marcellini M, Angulo P (2008) Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology 48:119–128
  46. Nobili Valerio, Marcellini Matilde, Devito Rita, Ciampalini Paolo, Piemonte Fiorella, Comparcola Donatella, Sartorelli Maria Rita, Angulo Paul, NAFLD in children: A prospective clinical-pathological study and effect of lifestyle advice, 10.1002/hep.21262
  47. Nobili Valerio, Monti Lidia, Alisi Anna, Zupone Cristina Lo, Pietrobattista Andrea, Tomà Paolo, Transient elastography for assessment of fibrosis in paediatric liver disease, 10.1007/s00247-011-2143-y
  48. Nobili Valerio, Svegliati-Baroni Gianluca, Alisi Anna, Miele Luca, Valenti Luca, Vajro Pietro, A 360-degree overview of paediatric NAFLD: Recent insights, 10.1016/j.jhep.2012.12.003
  49. Nobili Valerio, Vizzutti Francesco, Arena Umberto, Abraldes Juan G., Marra Fabio, Pietrobattista Andrea, Fruhwirth Rodolfo, Marcellini Matilde, Pinzani Massimo, Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis, 10.1002/hep.22376
  50. Pacifico Lucia, T1-weighted dual-echo MRI for fat quantification in pediatric nonalcoholic fatty liver disease, 10.3748/wjg.v17.i25.3012
  51. Patel Dharmendrakumar A., Srinivasan Sathanur R., Chen Wei, Berenson Gerald S., Serum Alanine Aminotransferase and Its Association with Metabolic Syndrome in Children: The Bogalusa Heart Study, 10.1089/met.2010.0086
  52. Perseghin Gianluca, The Role of Non-Alcoholic Fatty Liver Disease in Cardiovascular Disease, 10.1159/000282088
  53. Qayyum Aliya, Chen Daryl M., Breiman Richard S., Westphalen Antonio C., Yeh Benjamin M., Jones Kirk D., Lu Ying, Coakley Fergus V., Callen Peter W., Evaluation of diffuse liver steatosis by ultrasound, computed tomography, and magnetic resonance imaging: which modality is best?, 10.1016/j.clinimag.2008.06.036
  54. Reinehr T, Schmidt C, Toschke A M, Andler W, Lifestyle intervention in obese children with non-alcoholic fatty liver disease: 2-year follow-up study, 10.1136/adc.2008.143594
  55. Roberts Eve A., Pediatric nonalcoholic fatty liver disease (NAFLD): A “growing” problem?, 10.1016/j.jhep.2007.03.003
  56. Saadeh Sherif, Younossi Zobair M., Remer Erick M., Gramlich Terry, Ong Janus P., Hurley Maja, Mullen Kevin D., Cooper James N., Sheridan Michael J., The utility of radiological imaging in nonalcoholic fatty liver disease, 10.1053/gast.2002.35354
  57. Samuel Varman T., Liu Zhen-Xiang, Qu Xianqin, Elder Benjamin D., Bilz Stefan, Befroy Douglas, Romanelli Anthony J., Shulman Gerald I., Mechanism of Hepatic Insulin Resistance in Non-alcoholic Fatty Liver Disease, 10.1074/jbc.m313478200
  58. Schwimmer Jeffrey B., Behling Cynthia, Newbury Robert, Deutsch Reena, Nievergelt Caroline, Schork Nicholas J., Lavine Joel E., Histopathology of pediatric nonalcoholic fatty liver disease, 10.1002/hep.20842
  59. Schwimmer J. B., Deutsch R., Kahen T., Lavine J. E., Stanley C., Behling C., Prevalence of Fatty Liver in Children and Adolescents, 10.1542/peds.2006-1212
  60. Schwimmer J. B., Middleton M. S., Deutsch R., Lavine J. E., A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis, 10.1111/j.1365-2036.2005.02420.x
  61. Schwimmer J. B., Pardee P. E., Lavine J. E., Blumkin A. K., Cook S., Cardiovascular Risk Factors and the Metabolic Syndrome in Pediatric Nonalcoholic Fatty Liver Disease, 10.1161/circulationaha.107.739920
  62. Shannon Angela, Alkhouri Naim, Carter-Kent Christine, Monti Lidia, Devito Rita, Lopez Rocio, Feldstein Ariel E., Nobili Valerio, Ultrasonographic Quantitative Estimation of Hepatic Steatosis in Children With NAFLD : , 10.1097/mpg.0b013e31821b4b61
  63. Swiderska-Syn Marzena, Suzuki Ayako, Guy Cynthia D., Schwimmer Jeffrey B., Abdelmalek Manal F., Lavine Joel E., Diehl Anna Mae, Hedgehog pathway and pediatric nonalcoholic fatty liver disease, 10.1002/hep.26230
  64. Tiniakos Dina G., Vos Miriam B., Brunt Elizabeth M., Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis, 10.1146/annurev-pathol-121808-102132
  65. Vajro Pietro, Franzese Adriana, Valerio Giuliana, Iannucci Maria Pina, Aragione Nunzia, Lack of efficacy of ursodeoxycholic acid for the treatment of liver abnormalities in obese children, 10.1016/s0022-3476(00)26774-7
  66. Vajro Pietro, Lenta Selvaggia, Socha Piotr, Dhawan Anil, McKiernan Patrick, Baumann Ulrich, Durmaz Ozlem, Lacaille Florence, McLin Valerie, Nobili Valerio, Diagnosis of Nonalcoholic Fatty Liver Disease in Children and Adolescents : Position Paper of the ESPGHAN Hepatology Committee, 10.1097/mpg.0b013e318252a13f
  67. Vajro Pietro, Mandato Claudia, Franzese Adriana, Ciccimarra Edmondo, Lucariello Stefania, Savoia Marcella, Capuano Grazia, Migliaro Fiorella, Vitamin E Treatment in Pediatric Obesity-Related Liver Disease: A Randomized Study : , 10.1097/00005176-200401000-00012
  68. Vajro Pietro, Mandato Claudia, Licenziati Maria Rosaria, Franzese Adriana, Vitale Dino Franco, Lenta Selvaggia, Caropreso Maria, Vallone Gianfranco, Meli Rosaria, Effects of Lactobacillus rhamnosus Strain GG in Pediatric Obesity-related Liver Disease : , 10.1097/mpg.0b013e31821f9b85
  69. Wang Chun-Lin, Liang Li, Fu Jun-Fen, Zou Chao-Chun, Hong Fang, Xue Jin-Zheng, Lu Jin-Rui, Wu Xiang-Min, Effect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children, 10.3748/wjg.14.1598
  70. Weiner R.A., Surgical Treatment of Non-Alcoholic Steatohepatitis and Non-Alcoholic Fatty Liver Disease, 10.1159/000282102
  71. Widhalm K, Ghods E, Nonalcoholic fatty liver disease: a challenge for pediatricians, 10.1038/ijo.2010.185
  72. Xanthakos Stavra, Miles Lili, Bucuvalas John, Daniels Stephen, Garcia Victor, Inge Thomas, Histologic Spectrum of Nonalcoholic Fatty Liver Disease in Morbidly Obese Adolescents, 10.1016/s1542-3565(05)00978-x
  73. ZELMAN SAMUEL, THE LIVER IN OBESITY, 10.1001/archinte.1952.00240080007002